Xin Fu

Ms. Xin Fu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YCYanfen Cui
Yanfen Cui
SYShaobin Yang
Shaobin Yang
XFXin Fu
Xin Fu
JFJingwen Feng
Jingwen Feng
SXShilei Xu
Shilei Xu
GYGuoguang Ying
Guoguang Ying
KAP1 is an universal corepressor for Kruppel-associated box zinc finger proteins in both normal and tumor cells. In this study, the biological function and clinical significance of KAP1 expression in ovarian cancer were investigated. Immunohistological staining of KAP1 was evaluated in 111 patients with ovarian epithelial cancer, 15 with ovarian borderline tumor, and 20 normal ovarian tissue. The correlations of KAP1 expression with clinicopathological features were studied. Kaplan-Meier analysis and Cox proportional hazard modeling were used to assess overall survival to analyze the effect of KAP1 expression on the prognosis of ovarian cancer. The positive rates of KAP1 were significantly higher in ovarian epithelial cancer (55.7%) and borderline tumor (20.0%) than in normal ovarian tissue (5.0%) (all p < 0.01). KAP1 expression correlated significantly with clinical stage (χ2 = 14.57, p < 0.0001), pathological grade (χ2 = 6.06, p = 0.048) and metastases (χ2 =10.38, p = 0.001). Patients with high KAP 1 levels showed poor survival (p < 0.0001). Multivariate analysis showed that KAP1 high expression was an independent predictor for ovarian cancer patients (hazard ratio = 0.463; 95% confidence interval = 0.230–0.9318, p = 0.031). Functionally, depletion of KAP1 by siRNA inhibited ovarian cancer cell proliferation, cell migration. KAP1 expression correlated with aggressive clinical features in ovarian cancer. High KAP1 expression was a prognostic factor of ovarian cancer.

2 December 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
XFXin Fu
Xin Fu
YCYanfen Cui
Yanfen Cui
SYShaobin Yang
Shaobin Yang
YXYue Xu
Yue Xu
ZZZicheng Zhang
Zicheng Zhang

12 June 2026 in Oncology Letters
Verified
Journal Article
Open access
PDF file
JBJingchao Bai
Jingchao Bai
YXYihan Xu
Yihan Xu
KWKe Wang
Ke Wang
XFXin Fu
Xin Fu
Lactate‑to‑albumin ratio (LAR) may reflect metabolic dysregulation and nutritional status in critically ill patients. However, its association with long‑term prognosis in intensive care unit (ICU) patients with malignant tumors requires further elucidation. The present study was conducted to assess the association between LAR and 30‑day and 360‑day all‑cause mortality in ICU patients with malignant tumors and to investigate the potential non‑linear associations and subgroup differences. A total of 1,634 ICU patients with malignant tumors were enrolled. Baseline clinical data were collected and LAR was calculated. Survival differences across LAR tertiles were analyzed using Kaplan‑Meier curves with the log‑rank test. Univariate and multivariate Cox regression models (with stepwise adjustment for confounders) were employed to evaluate the independent predictive value of LAR for all‑cause mortality. A restricted cubic spline model was used to analyze the non‑linear association and subgroup interaction tests were conducted to verify the stability of the LAR effect. The 30‑day mortality rates for the three tertile groups were 23, 31 and 43%, respectively, while the 360‑day mortality rates were 51, 56 and 67%. Mortality significantly increased with higher LAR tertiles (P<0.001). Multivariate Cox regression analysis, after adjusting for confounders, identified LAR as an independent risk factor for both 30‑day [hazard ratio (HR)=1.13; 95% CI: 1.04‑1.22; P=0.004] and 360‑day (HR=1.15; 95% CI: 1.07‑1.23; P<0.001) all‑cause mortality. Restricted cubic spline analysis indicated a linear association between LAR and mortality risk. Subgroup analysis revealed no significant interaction effects. Overall, LAR was identified to be an independent predictor of 30‑day and 360‑day all‑cause mortality in ICU patients with malignant tumors, exhibiting a linear positive association with mortality risk. Its predictive effect remains stable across different subgroups, suggesting its potential as a prognostic indicator in this patient population.

8 May 2017 in Preprints.org
Verified
Preprint
Open access
PDF file
YCYanfen Cui
Yanfen Cui
ZWZhaosong Wang
Zhaosong Wang
SYShaobin Yang
Shaobin Yang
YXYue Xu
Yue Xu
XFXin Fu
Xin Fu
Tripartite motif containing 28 (TRIM28) is a transcriptional co-factor with pleiotropic biological activities, especially in tumor cells. In this study, expression levels of TRIM28 in osteosarcoma (OS) tissues and the correlations with clinicopathological variables were investigated in 87 OS cases, meanwhile, cell and animal experiments were performed to detect the biological functions of TRIM28. The results showed that TRIM28 was overexpressed in OS tissues compared with normal bones, and TRIM28 expression correlated significantly with tumor diameter (χ2 = 4.06, p=0.04), metastasis (χ2 =11.10, p< 0.01) and clinical stage (χ2 =15.50, p< 0.01). Furthermore, patients with high TRIM28 level always had poor survival (p < 0.01). Functionally, TRIM28 knockdown significantly inhabited cell ability of proliferation and migration in OS cell lines of in vitro and in vivo experiments. Additionally, TRIM28 could significantly inhibited E-cadherin expression in reducing the stability of the TRIM28 mRNA. Therefore, TRIM28 overexpression was correlated with malignant progression of OS and poor survival of OS patients, and TRIM28 pathway may be a therapeutic target for OS.